Surgery Partners

Forecast & Rating7 analysts currently cover Surgery Partners, with about 42.9% giving a positive rating — meaning they expect the stock to rise. The average price target is $21.20, about 8.8% downside from the current price of $23.25. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 33.5% of past price targets were eventually met, which adds credibility. For you, this means institutional views on Surgery Partners are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Oct 27, 2026; for reference only and not investment advice.